• Aurobindo gets final approval for Omeprazole
Aurobindo Pharma announced that the company has received the final approval from the US Food & Drug Administration ( USFDA) to manufacture and market Omeprazole Delayed-release Capsules USP, 10mg, 20mg and 40mg. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Prilosec® Delayed-release Capsules, 10mg, 20mg and 40mg of AstraZeneca Pharmaceuticals.
• Sun Pharma gets USFDA approval for Ximino
Sun Pharma gets USFDA approval for Ximino: Positive for the company .Sun Pharma gets US FDA approval for Supplemental New Drug Application (sNDA) for Ximino. This approval further strengthens the Company’s branded dermatology portfolio in the US. It expects Ximino TM extended-release capsules to be available for patients during the fourth quarter of 2015.
• Aurobindo receives USFDA approval for Ibandronate
Aurobindo Pharma announced that the company has received final approvals from the US Food & Drug Administration ( USFDA) to manufacture and market Ibandronate Sodium Injection, 3mg/3mL (1mg/mL).
Ibandronate Sodium Injection, 3mg/3mL (1mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Boniva® Injection, 3mg/3mL (1mg/mL) of Hoffmann-La Roche, Inc. Ibandronate Sodium Injection is indicated for the treatment of osteoporosis in postmenopausal women.
• Crude oil declines further; Brent at $47
Crude oil declined further; Brent at $47 and WTI at $ 40, new low - Positive for OMC’s , Paints, Lubricants and Tyre companies .Crude Oil ( Brent) has slipped again and is now trading below 5 year low at $ 46.92, while WTI Oil is hovering around $40. As a result the industries which use crude and its derivatives are expected to be beneficial. Positive for OMCs (HPCL, BPCL), Paint (Asian Paints) and lubricants (Castrol, Gulf oil lubricant)
• Ratnamani Metals bags new order worth Rs159.40 cr
Ratnamani Metals & Tubes has announced that the Company has bagged an order for supply of coated CS pipes from Reliance Gas Pipelines amounting to Rs159.40 crores (net of taxes and duties) to be completed in current financial year.
• JSW Steel to invest Rs5000 cr on capital expenditure
JSW Steel has said that it is planning to invest about Rs5,000 crore on various capital expenditure projects in this fiscal ending March 2016, as per reports. Commenting on the issue, JSW Steel Chairman and Managing Director Sajjan Jindal told the media, 'The company is expected to invest approximately Rs 5,000 crore during FY16 on various capital expenditure programmes.'
No comments:
Post a Comment